secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0001799191-23-000037
Event type: earnings
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncology Institute releases Q2 2023 results and 2023 guidance; no specific figures in filing text
--------------------------------------------------------------------------------

- Company furnished slide presentation with Q2 and H1 2023 financial results on August 10, 2023.
- Management provided updated business guidance for the year ending December 31, 2023.
- No revenue, EPS, or other numeric details are extractable from the available filing exhibits.
- Tickers: TOI (common stock) and TOIIW (warrants).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000037/0001799191-23-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000037/toi-20230810.htm
  HTML page:      https://secwatch.observer/filing/0001799191-23-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer